226 related articles for article (PubMed ID: 29970331)
21. Attention-deficit hyperactivity disorder, its pharmacotherapy, and the risk of developing bipolar disorder: A nationwide population-based study in Taiwan.
Wang LJ; Shyu YC; Yuan SS; Yang CJ; Yang KC; Lee TL; Lee SY
J Psychiatr Res; 2016 Jan; 72():6-14. PubMed ID: 26519764
[TBL] [Abstract][Full Text] [Related]
22. Attention deficit hyperactivity disorder and risk of migraine: A nationwide longitudinal study.
Hsu TW; Chen MH; Chu CS; Tsai SJ; Bai YM; Su TP; Chen TJ; Liang CS
Headache; 2022 May; 62(5):634-641. PubMed ID: 35524451
[TBL] [Abstract][Full Text] [Related]
23. Pharmacotherapy May Attenuate the Risk of Child Abuse in Attention-Deficit/Hyperactivity Disorder from the Real-World Evidence.
Lin CC; Chung CH; Chien WC; Tzeng NS
J Child Adolesc Psychopharmacol; 2023 Mar; 33(2):59-68. PubMed ID: 36944094
[No Abstract] [Full Text] [Related]
24. Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan.
Wang LJ; Yang KC; Lee SY; Yang CJ; Huang TS; Lee TL; Yuan SS; Shyu YC
PLoS One; 2016; 11(8):e0161061. PubMed ID: 27518196
[TBL] [Abstract][Full Text] [Related]
25. The association between attention deficit hyperactivity disorder severity and risk of mild traumatic brain injury in children with attention deficit hyperactivity disorder in the United States of America: A cross-sectional study of data from the National Survey of Children with Special Health Care Needs.
Karic S; DesRosiers M; Mizrahi B; Zevallos J; Rodriguez P; Barengo NC
Child Care Health Dev; 2019 Sep; 45(5):688-693. PubMed ID: 31049988
[TBL] [Abstract][Full Text] [Related]
26. Incidence and risk of attention-deficit hyperactivity disorder in children with amblyopia: A nationwide cohort study.
Su CC; Tsai CY; Tsai TH; Tsai IJ
Clin Exp Ophthalmol; 2019 Mar; 47(2):259-264. PubMed ID: 30663207
[TBL] [Abstract][Full Text] [Related]
27. Increased Risk of Traumatic Injuries Among Parents of Children with Attention Deficit/Hyperactivity Disorder: A Nationwide Population-Based Study.
Li DJ; Chen YL; Chen YY; Hsiao RC; Lu WH; Yen CF
Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33808366
[TBL] [Abstract][Full Text] [Related]
28. Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study.
Mikolajczyk R; Horn J; Schmedt N; Langner I; Lindemann C; Garbe E
JAMA Pediatr; 2015 Apr; 169(4):391-5. PubMed ID: 25686215
[TBL] [Abstract][Full Text] [Related]
29. Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications.
Setyawan J; Guérin A; Hodgkins P; Gauthier G; Cloutier M; Wu E; Erder MH
J Med Econ; 2013 Nov; 16(11):1275-89. PubMed ID: 24004347
[TBL] [Abstract][Full Text] [Related]
30. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
[TBL] [Abstract][Full Text] [Related]
31. Exposure to Surgery and Anesthesia in Early Childhood and Subsequent Use of Attention Deficit Hyperactivity Disorder Medications.
Ing C; Ma X; Sun M; Lu Y; Wall MM; Olfson M; Li G
Anesth Analg; 2020 Sep; 131(3):723-733. PubMed ID: 31923004
[TBL] [Abstract][Full Text] [Related]
32. Prevalence, incidence, and stimulant use of attention-deficit hyperactivity disorder in Taiwan, 1996-2005: a national population-based study.
Chien IC; Lin CH; Chou YJ; Chou P
Soc Psychiatry Psychiatr Epidemiol; 2012 Dec; 47(12):1885-90. PubMed ID: 22476209
[TBL] [Abstract][Full Text] [Related]
33. Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
Moran LV; Ongur D; Hsu J; Castro VM; Perlis RH; Schneeweiss S
N Engl J Med; 2019 Mar; 380(12):1128-1138. PubMed ID: 30893533
[TBL] [Abstract][Full Text] [Related]
34. Higher risk of developing mood disorders among adolescents with comorbidity of attention deficit hyperactivity disorder and disruptive behavior disorder: a nationwide prospective study.
Chen MH; Su TP; Chen YS; Hsu JW; Huang KL; Chang WH; Chen TJ; Bai YM
J Psychiatr Res; 2013 Aug; 47(8):1019-23. PubMed ID: 23643104
[TBL] [Abstract][Full Text] [Related]
35. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
Bhang SY; Hwang JW; Kwak YS; Joung YS; Lee S; Kim B; Sohn SH; Chung US; Yang J; Hong M; Bahn GH; Choi HY; Oh IH; Lee YJ
J Korean Med Sci; 2016 Aug; 31(8):1284-91. PubMed ID: 27478341
[TBL] [Abstract][Full Text] [Related]
36. Methylphenidate treatment of attention-deficit/hyperactivity disorder secondary to traumatic brain injury: a critical appraisal of treatment studies.
Jin C; Schachar R
CNS Spectr; 2004 Mar; 9(3):217-26. PubMed ID: 14999162
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
Goldman LS; Genel M; Bezman RJ; Slanetz PJ
JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
[TBL] [Abstract][Full Text] [Related]
38. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
[TBL] [Abstract][Full Text] [Related]
39. Health-related quality of life in prisoners with attention-deficit hyperactivity disorder and head injury.
Young S; González RA; Fridman M; Hodgkins P; Kim K; Gudjonsson GH
BMC Psychiatry; 2018 Jun; 18(1):209. PubMed ID: 29929487
[TBL] [Abstract][Full Text] [Related]
40. Sleep and quality of life in children with traumatic brain injury and ADHD.
Ekinci O; Okuyaz Ç; Günes S; Ekinci N; Örekeci G; Teke H; Çobanoğulları Direk M
Int J Psychiatry Med; 2017 Jan; 52(1):72-87. PubMed ID: 28486878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
